Haluk Özen

856 total citations
45 papers, 623 citations indexed

About

Haluk Özen is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Rheumatology. According to data from OpenAlex, Haluk Özen has authored 45 papers receiving a total of 623 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pulmonary and Respiratory Medicine, 20 papers in Surgery and 12 papers in Rheumatology. Recurrent topics in Haluk Özen's work include Prostate Cancer Diagnosis and Treatment (24 papers), Prostate Cancer Treatment and Research (23 papers) and Urologic and reproductive health conditions (12 papers). Haluk Özen is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (24 papers), Prostate Cancer Treatment and Research (23 papers) and Urologic and reproductive health conditions (12 papers). Haluk Özen collaborates with scholars based in Türkiye, United States and Italy. Haluk Özen's co-authors include Si̇nan Eki̇ci̇, Saadettin Eskiçorapçı, Ali̇ Ergen, Dilek Ertoy Baydar, Sinan Sözen, Cem Akbal, Mustafa Sofikerim, Levent Mert Günay, A. Ayhan and Bülent Akdoğan and has published in prestigious journals such as The Journal of Urology, European Urology and Urology.

In The Last Decade

Haluk Özen

39 papers receiving 601 citations

Peers

Countries citing papers authored by Haluk Özen

Since Specialization

Citations

This map shows the geographic impact of Haluk Özen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haluk Özen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haluk Özen more than expected).

Fields of papers citing papers by Haluk Özen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haluk Özen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haluk Özen. The network helps show where Haluk Özen may publish in the future.

Co-authorship network of co-authors of Haluk Özen

This figure shows the co-authorship network connecting the top 25 collaborators of Haluk Özen. A scholar is included among the top collaborators of Haluk Özen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haluk Özen. Haluk Özen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Are the Recommended Criteria for Clinically Insignificant Prostate Cancer Applicable to 12-core Prostate Biopsy Scheme? A Multicentre Study of Urooncology Association, Turkey 2021 ·Serdar Çelik, Fuat Kızılay, Kutsal Yörükoğlu, Haluk Özen, Bülent Akdoğan, Volkan İzol, Yıldırım Bayazıt, Güven Aslan, Sinan Sözen, Sümer Baltacı, Talha Müezzi̇noğlu, Fehmi Narter, Levent Türkeri	0
2	The effect of risk factors on surgical and oncological results in high‐risk prostate cancer: A multicentre study of the urooncology society, Turkey 2021 ·International Journal of Clinical Practice ·Volkan İzol, (unknown), Haluk Özen, Bülent Akdoğan, Ali Rıza Kural, Mustafa Bilal Tuna, Sinan Sözen, Levent Türkeri, (unknown), Sümer Baltacı, Ender Özden, Yakup Kordan, Yıldırım Bayazıt, Güven Aslan, (unknown), Talha Müezzi̇noğlu, Çağ Çal	0
3	Sextant Biopsy-Based Criteria for Clinically Insignificant Prostate Cancer Are Also Valid for the 12-Core Prostate Biopsy Scheme: A Multicenter Study of Urooncology Association, Turkey 2021 ·Urologia Internationalis ·Serdar Çelik, Fuat Kızılay, Kutsal Yörükoğlu, Güven Aslan, Haluk Özen, Bülent Akdoğan, Sinan Sözen, Sümer Baltacı, Talha Müezzi̇noğlu, Volkan İzol, Yıldırım Bayazıt, Fehmi Narter, Levent Türkeri	0
4	Should Targeted Biopsy be Performed in Patients Who Have Only Pi-rads 3 Lesions? 2021 ·Archivos Españoles de Urología ·(unknown), (unknown), (unknown), Bülent Akdoğan, Haluk Özen, Güven Aslan, Levent Türkeri	2
5	Correlation of Prostate-Imaging Reporting and Data Scoring System scoring on multiparametric prostate magnetic resonance imaging with histopathological factors in radical prostatectomy material in Turkish prostate cancer patients: a multicenter study of the Urooncology Association 2020 ·Prostate International ·Fuat Kızılay, Serdar Çelik, Sinan Sözen, (unknown), Saadettin Eskiçorapçı, (unknown), Haluk Özen, Bülent Akdoğan, Güven Aslan, Fehmi Narter, Çağ Çal, Levent Türkeri	22
6	Determination of risk factors for progression in patients with viable tumor at post-chemotherapy lymph node dissection due to disseminated non-seminomatous germ-cell tumors 2020 ·International Journal of Clinical Oncology ·Mesut Altan, Hakan Bahadır Haberal, (unknown), Ahmet Güdeloğlu, Ahmet Doğrul, Sertaç Yazıcı, (unknown), Haluk Özen	0
7	Factors Affecting Surgical Margin Positivity after Radical Prostatectomy in the Turkish Population: A Multicenter Study of the Urooncology Association 2020 ·Urologia Internationalis ·Serdar Çelik, Güven Aslan, Sinan Sözen, Haluk Özen, Bülent Akdoğan, Sümer Baltacı, Volkan İzol, (unknown), Levent Türkeri	6
8	Pathologic Outcomes of Candidates for Active Surveillance Undergoing Radical Prostatectomy: Results from a Contemporary Turkish Patient Cohort 2017 ·Urologia Internationalis ·İlker Tınay, Güven Aslan, Ali Rıza Kural, Haluk Özen, Bülent Akdoğan, Asıf Yıldırım, (unknown), Alp Özkan, Tarık Esen, Ferruh Zorlu, Özdal Dillioğlugil, Nural Bekiroğlu, Levent Türkeri	4
9	The nomogram conundrum: a demonstration of why a prostate cancer risk model in Turkish men underestimates prostate cancer risk in the USA 2016 ·International Urology and Nephrology ·Önder Kara, Ahmed Elshafei, Yaw A. Nyame, Bülent Akdoğan, Ercan Malkoç, Tianming Gao, Mesut Altan, (unknown), (unknown), (unknown), Daniel Greene, Temuçin Şenkul, Ferhat Ateş, Haluk Özen, J. Stephen Jones	1
10	Comparison of the Efficacy of Single or Double Intravesical Epirubicin Instillation in the Early Postoperative Period to Prevent Recurrences in Non-Muscle-Invasive Urothelial Carcinoma of the Bladder: Prospective, Randomized Multicenter Study 2010 ·Urologia Internationalis ·Levent Türkeri, Yılören Tanıdır, Çağ Çal, Haluk Özen, (unknown), (unknown)	3
11	Validation of Two Preoperative Kattan Nomograms Predicting Recurrence After Radical Prostatectomy for Localized Prostate Cancer in Turkey: A Multicenter Study of the Uro-oncology Society 2009 ·Urology ·Saadettin Eskiçorapçı, Levent Türkeri, Erdem Karabulut, Çağ Çal, Haluk Akpınar, Sümer Baltacı, (unknown), Michael W. Kattan, Haluk Özen	7
12	Increasing the number of biopsies increases the concordance of Gleason scores of needle biopsies and prostatectomy specimens 2007 ·Urologic Oncology Seminars and Original Investigations ·Rauf Taner Di̇vri̇k, (unknown), Ali̇ Şahi̇n, Ferruh Zorlu, Haluk Özen	63
13	The Effect of Prior Biopsy Scheme on Prostate Cancer Detection for Repeat Biopsy Population: Results of the 14-core Prostate Biopsy Technique 2006 ·International Urology and Nephrology ·Saadettin Eskiçorapçı, (unknown), (unknown), Ali̇ Ergen, Haluk Özen	28
14	Proliferating‐cell nuclear antigen (PCNA) as an independent prognostic marker in patients after prostatectomy: a comparison of PCNA and Ki‐67 2005 ·British Journal of Urology ·(unknown), A. Ayhan, Si̇nan Eki̇ci̇, Ali̇ Ergen, Haluk Özen	30
15	Resection of pulmonary metastases following chemotherapy for high stage testicular tumors 2004 ·International Journal of Urology ·Saadettin Eskiçorapçı, Si̇nan Eki̇ci̇, (unknown), (unknown), Haluk Özen	4
16	Resection of residual masses alone: an alternative in surgical therapy of metastatic testicular germ cell tumors after chemotherapy 2001 ·Urology ·Haluk Özen, Si̇nan Eki̇ci̇, (unknown), Ali̇ Ergen, Serdar Tekgül, Sezer Kendi̇	19
17	Combined Use of Prostate-Specific Antigen Derivatives Decreases the Number of Unnecessary Biopsies to Detect Prostate Cancer 2001 ·American Journal of Clinical Oncology ·Haluk Özen, Cem Aygün, Ali̇ Ergen, Sinan Sözen, Fazıl Tuncay Aki, M. Cemil Uygur	16
18	Bladder cancer 1999 ·Current Opinion in Oncology ·Haluk Özen	15
19	Multicentricity in Renal Cell Carcinoma 1999 ·International Urology and Nephrology ·Cenk Yücel Bilen, Kamran Mahalati, Haluk Özen, Fazıl Tuncay Aki, C Ilyas, Sezer Kendi̇	5
20	Transitional cell carcinoma of the bladder 1994 ·Current Opinion in Oncology ·Haluk Özen	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact